Skip to main content
SpringerLink
Log in

Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rats were chronically injected with saline, clozapine, or haloperidol and tested for alterations in dopamine (DA)-mediated behavior, DA receptor binding, and both acetylcholine (ACH) concentration and cholien acetylase activity. Behaviorally, chronic haloperidol significantly enhanced apomorphine-induced chewing and sniffing stereotypies, associated with DA nigrostriatal activation, while clozapine selectively enhanced apomorphine locomotor activity and cage-floor crossing, behavior associated with DA mesolimbic activation. Biochemically, chronic haloperidol significantly enhanced 3H-spiroperidol binding in striatum and in mesolimbic loci (nucleus accumbens/olfactory tuberele) while chronic clozapine failed to produce such enhancement. Acute haloperidol induced an initial decrease in striatal ACH concentration followed by a return of ACH to normal levels within 1 week. There was no change in choline acetylase activity during the same time interval. These findings suggest that haloperidol may inhibit DA mechanisms in both the nigrostriatal and mesolimbic systems, but that the effect of clozapine on DA mechanisms may be specific to mesolimbic rather than striatal structures. At the same time, the lack of effect of clozapine on 3H-spiroperidol binding may indicate that behaviorally important changes in DA sensitivity can develop independent of changes in post-synaptic DA receptors. The pattern of cholinergic changes with chronic haloperidol suggests that the increase in striatal DA receptor number seen with chronic treatment re-establishes DA inhibition of cholinergic firing within the striatum.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ackenheil M, Hippius H (1977) Clozapine. In: Usdin E, Forrest IS (eds) Psychotherapeutic drugs. Marcel Dekker, New York, pp 923–956

    Google Scholar 

  • Andén N-E, Stock G (1973) Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J Pharm Pharmacol 25:346–348

    Google Scholar 

  • Atweh S, Simon JR, Kuhar MJ (1975) Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. Life Sci 17:1535–1544

    Google Scholar 

  • Bartholini G (1977) Preferential effect of noncataleptogenic neuroleptics on mesolimbic dopaminergic function. Adv Biochem Psychopharmacol 16:607–611

    Google Scholar 

  • Borison RL, Bauer ML, Havdala HS, Diamond BI (1980) Thioridazine and extrapyramidal system side effects: evidence for a site specificity. Neurology 30:394–395

    Google Scholar 

  • Burt DR, Creese I, Snyder SH (1977) Anti-schizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196:326–328

    Google Scholar 

  • Connor JD (1970) Caudate nucleus neurons: correlation of the effects of substantia nigra stimulation with iontophoretic dopamine. J Physiol 208:691–703

    Google Scholar 

  • Consolo S, Ladinsky H, Bianchi S (1975) Decrease in rat striatal acetylcholine levels by some direct and indirect acting dopaminergic antagonists. Eur J Pharmacol 33:345–351

    Google Scholar 

  • Costall B, Naylor RJ (1976) A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metaclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Eur J Pharmacol 40:9–19

    Google Scholar 

  • Costall B, Naylor RJ (1977) Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat. Adv Behav Biol 21:47–76

    Google Scholar 

  • Creese I, Burt D, Snyder SH (1977) Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. Science 197:596–598

    Google Scholar 

  • Datta K, Thal L, Wajda IJ (1971) Effects of morphine on choline acetyltransferase levels in the caudate nucleus of the rat. Br J Pharmacol 41:84–93

    Google Scholar 

  • Gardner EL, Zukin RS, Gintzler AR (1982) Mechanisms of supersensitivity in the enkephalinergic system. In: Takagi H, Simon EJ (eds) Advances in endogenous and exogenous opioids. Pergamon Press, New York, to be published

    Google Scholar 

  • Gnegy ME, Luchelli A, Costa E (1977) Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase. Naunyn-Schmiedeberg's Arch Pharmacol 301:121–127

    Google Scholar 

  • Guidotti A, Gale K, Toffano G, Vargas FM (1978) Tolerance to tyrosine hydroxylase activation in n. accumbens and c. striatum after repeated injections of “classical” and “atypical” antischizophrenic drugs. Life Sci 23:501–506

    Google Scholar 

  • Guyenett PG, Javoy F, Euvrard C, Glowinski J (1977) The effect of drugs on the choline and acetylcholine content of the rat striatum following two methods of sacrifice. Neuropharmacology 16:385–390

    Google Scholar 

  • Hong JS, Yang HT, Costa E (1978a) Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs. Neuropharmacology 17:83–85

    Google Scholar 

  • Hong JS, Yang HT, Fratta W, Costa E (1978b) Rat striatal methionineenkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J Pharmacol Exp Ther 205:141–147

    Google Scholar 

  • Howlett DR, Nahorski SR (1979) Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites. Brain Res 161:173–178

    Google Scholar 

  • Huff RM, Adams RN (1980) Dopamine release in n. accumbens and striatum by clozapine: stimultaneous monitoring by in vivo electrochemistry. Neuropharmacology 19:587–590

    Google Scholar 

  • Hyttel J (1978) Dopamine-receptor binding and adenylate-cycalse activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment. Psychopharmacology 59:211–216

    Google Scholar 

  • Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522

    Google Scholar 

  • Klawans HL, Margolin DI (1975) Amphetamine-induced dopaminergic hypersensitivity in guinea-pigs. Arch Gen Psychiatry 32:725–732

    Google Scholar 

  • Klawans HL, Goetz C, Nausieda PA, Weiner WJ (1977) Levodopa-induced dopamine receptor hypersensitivity. Ann Neurol 2:125–129

    Google Scholar 

  • Kobayashi RM, Fields JZ, Hruska RE, Beaumont K, Yamamura HI (1977) Brain neurotransmitter receptors and chronic antipsychotic drug treatment: a model for tardive dyskinesia. In: Hanin I, Usdin E (eds) Animal models in psychiatry and neurology. Pergamon Press, New York, pp 405–409

    Google Scholar 

  • Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978) Serotonergic component of neuroleptic receptors. Nature 272:168–171

    Google Scholar 

  • Ljungberg T, Ungerstedt U (1978) Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action. Psychopharmacology 56:239–247

    Google Scholar 

  • Mao CC, Cheney DL, Marco E, Revuelta A, Costa E (1977) Turnover times of gamma-aminobutyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol. Brain Res 132:375–379

    Google Scholar 

  • McGeer PL, Grewaal DS, McGeer EG (1974) Influence of noncholinergic drugs on rat striatal acetylcholine levels. Brain Res 80:211–217

    Google Scholar 

  • McGeer PL, McGeer EG, Fibiger HC, Wichson V (1971) Neostriatal choline acetylase and cholinesterase following selective brain lesions. Brain Res 35:308–315

    Google Scholar 

  • Muller P, Seeman P (1977) Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors. Life Sci 21:1751–1758

    Google Scholar 

  • Muller P, Seeman P (1978) Dopaminergic supersensitivity after neuroleptics: time-course and specificity. Psychopharmacology 60:1–11

    Google Scholar 

  • Ohman R, Larsson M, Nilsson IM, Engel J, Carlsson A (1977) Neurometabolic and behavioral effects of haloperidol in relation to drug levels in serum and brain. Naunyn-Schmiedeberg's Arch Pharmacol 299:105–114

    Google Scholar 

  • Pijnenberg AJJ, Van Rossum JM (1973) Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J Pharm Pharmacol 25:1003–1005

    Google Scholar 

  • Saelens JK, Simke JP, Allen MA, Conroy CA (1973) Measurement of choline, acetylcholine and their metabolites by combined enzymatic and radiometric techniques. In: Fried E (ed) Methods of neurochemistry, vol 4. Marcel Dekker, New York, pp 69–81

    Google Scholar 

  • Sayers AC, Bürki HR, Ruch W, Asper H (1975) Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia 41:97–104

    Google Scholar 

  • Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M (1978) Modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines. Neuropharmacology 17:665–685

    Google Scholar 

  • Seeger TF, Gardner EL (1979) Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity. Brain Res 175:49–57

    Google Scholar 

  • Seeger TF, Nazzaro JM, Gardner EL (1980) Selective inhibition of mesolimbic behavioral supersensitivity by naloxone. Eur J Pharmacol 65:435–438

    Google Scholar 

  • Sethy VH (1976) Effects of chronic treatment with neuroleptics on striatal acetylcholine concentration. J Neurochem 27:325–326

    Google Scholar 

  • Sethy VH, Van Woert MH (1974a) Regulation of striatal acetylcholine concentration by dopamine receptors. Nature 241:529–530

    Google Scholar 

  • Sethy VH, Van Woert MH (1974b) Brain acetylcholine and cholinesterase: effect of phenothiazines and physostigmine interaction in rats. J Neurochem 23:105–109

    Google Scholar 

  • Stille G, Ackermann H, Eichenberger E, Lauener H (1965) The pharmacological properties of a potent neurotropic compound from the dibenzodiazepine group. Int J Neuropharmacol 4:375–391

    Google Scholar 

  • Thal L, Mishra RK, Gardner EL, Horowitz SG, Varmuza S, Makman MH (1979) Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes. Brain Res 170:381–386

    Google Scholar 

  • Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand (Suppl) 367:69–93

    Google Scholar 

  • Zivkovic B, Guidotti A, Revuelta A, Costa E (1975) Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens. J Pharmacol Exp Ther 194:37–46

    Google Scholar 

Download references

Author information

Author notes

  1. Thomas. F. Seeger

    Present address: Department of Pharmacology, University of Massachusetts Medical Center, Worcester, Massachusetts, USA

Authors and Affiliations

  1. Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, USA

    Thomas. F. Seeger, Leon Thal & Eliot L. Gardner

  2. Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA

    Thomas. F. Seeger, Leon Thal & Eliot L. Gardner

  3. Department of Psychiatry, Albert Einstein College of Medicine, Bronx, New York, USA

    Thomas. F. Seeger, Leon Thal & Eliot L. Gardner

  4. Department of Neuroscience, Albert Einstein College of Medicine, Bronx, New York, USA

    Thomas. F. Seeger, Leon Thal & Eliot L. Gardner

Authors
  1. Thomas. F. Seeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leon Thal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eliot L. Gardner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seeger, T.F., Thal, L. & Gardner, E.L. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: Studies with chronic clozapine and haloperidol. Psychopharmacology 76, 182–187 (1982). https://doi.org/10.1007/BF00435275

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00435275

Key words

Search

Navigation